Literature DB >> 12665600

Characteristics of 24 h telemetered blood pressure in eNOS-knockout and C57Bl/6J control mice.

Bruce N Van Vliet1, Linda L Chafe, Jean-Pierre Montani.   

Abstract

The purpose of the present study was to characterize in detail the 24 h blood pressure (BP) phenotype of mice lacking the gene for endothelial nitric oxide synthase (eNOS-/-) and the corresponding control strain (C57Bl/6J). Twenty-four hour BP recordings were made in conscious 12- to 16-week-old male mice 10 days following the implantation of a BP telemeter (n = 9 per group). The BP and heart rate of both strains were markedly affected by brief locomotor activity cycles, resulting in bimodal distributions of BP and heart rate within both light and dark periods. Data from active periods were associated with the higher of the two modes, whereas data from inactive periods were associated with the lower of the two modes. In eNOS-/- mice, the 24 h average BP level was significantly elevated (+15 %, 104 +/- 2 vs. 119 +/- 1 mmHg), as was its daily range (+44 %), its coefficient of variation (+26 %), dark-light difference (+48 %), and the separation of the two modes of its distribution (+41 %). Pulse pressure was also significantly greater (+23 %) in eNOS-/- mice. The 24 h heart rate level did not differ between control and eNOS-/- mice. Considerable variation was noted among previously published values of BP in eNOS-/- mice, but not in the corresponding control mice. Our results indicate that eNOS-/- mice have mild hypertension that is accompanied by more pronounced increases in BP lability and/or reactivity. Our results also demonstrate a marked effect of locomotor activity on BP in mice, which may confound short-term measurements of BP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12665600      PMCID: PMC2342911          DOI: 10.1113/jphysiol.2003.041897

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  38 in total

1.  Direct and indirect methods used to study arterial blood pressure.

Authors:  B N Van Vliet; L L Chafe; V Antic; S Schnyder-Candrian; J P Montani
Journal:  J Pharmacol Toxicol Methods       Date:  2000 Sep-Oct       Impact factor: 1.950

2.  Long-term telemetric recording of arterial pressure and heart rate in mice fed basal and high NaCl diets.

Authors:  S H Carlson; J M Wyss
Journal:  Hypertension       Date:  2000-02       Impact factor: 10.190

Review 3.  Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism.

Authors:  S K Wattanapitayakul; M J Mihm; A P Young; J A Bauer
Journal:  Trends Pharmacol Sci       Date:  2001-07       Impact factor: 14.819

4.  Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo.

Authors:  S Kinlay; M A Creager; M Fukumoto; H Hikita; J C Fang; A P Selwyn; P Ganz
Journal:  Hypertension       Date:  2001-11       Impact factor: 10.190

5.  Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats.

Authors:  R M Fitch; R Vergona; M E Sullivan; Y X Wang
Journal:  Cardiovasc Res       Date:  2001-08-01       Impact factor: 10.787

6.  Characteristics of the pulse waveform during altered nitric oxide synthesis in the rabbit.

Authors:  P D Weinberg; F Habens; M Kengatharan; S E Barnes; J Matz; E E Anggård; M J Carrier
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

7.  A new method for measurement of blood pressure, heart rate, and activity in the mouse by radiotelemetry.

Authors:  P A Mills; D A Huetteman; B P Brockway; L M Zwiers; A J Gelsema; R S Schwartz; K Kramer
Journal:  J Appl Physiol (1985)       Date:  2000-05

8.  Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase.

Authors:  H Duplain; R Burcelin; C Sartori; S Cook; M Egli; M Lepori; P Vollenweider; T Pedrazzini; P Nicod; B Thorens; U Scherrer
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

9.  Alcohol hypersensitivity, increased locomotion, and spontaneous myoclonus in mice lacking the potassium channels Kv3.1 and Kv3.3.

Authors:  F Espinosa; A McMahon; E Chan; S Wang; C S Ho; N Heintz; R H Joho
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

10.  An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice.

Authors:  R P Brandes; F H Schmitz-Winnenthal; M Félétou; A Gödecke; P L Huang; P M Vanhoutte; I Fleming; R Busse
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

View more
  42 in total

1.  Na+-sensitive elevation in blood pressure is ENaC independent in diet-induced obesity and insulin resistance.

Authors:  Jonathan M Nizar; Wuxing Dong; Robert B McClellan; Mariana Labarca; Yuehan Zhou; Jared Wong; Donald G Goens; Mingming Zhao; Nona Velarde; Daniel Bernstein; Michael Pellizzon; Lisa M Satlin; Vivek Bhalla
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-03

2.  Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice.

Authors:  Hui John Zhao; Suwan Wang; Huifang Cheng; Ming-zhi Zhang; Takamune Takahashi; Agnes B Fogo; Matthew D Breyer; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2006-09-13       Impact factor: 10.121

3.  Reduced alpha-adrenoceptor responsiveness and enhanced baroreflex sensitivity in Cry-deficient mice lacking a biological clock.

Authors:  Shizue Masuki; Takeshi Todo; Yasushi Nakano; Hitoshi Okamura; Hiroshi Nose
Journal:  J Physiol       Date:  2005-04-28       Impact factor: 5.182

4.  Persistence of circadian variation in arterial blood pressure in beta1/beta2-adrenergic receptor-deficient mice.

Authors:  Soo Mi Kim; Yuning Huang; Yan Qin; Diane Mizel; Jurgen Schnermann; Josephine P Briggs
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-02-27       Impact factor: 3.619

5.  Increased catecholamine secretion contributes to hypertension in TRPM4-deficient mice.

Authors:  Ilka Mathar; Rudi Vennekens; Marcel Meissner; Frieder Kees; Gerry Van der Mieren; Juan E Camacho Londoño; Sebastian Uhl; Thomas Voets; Björn Hummel; An van den Bergh; Paul Herijgers; Bernd Nilius; Veit Flockerzi; Frank Schweda; Marc Freichel
Journal:  J Clin Invest       Date:  2010-08-02       Impact factor: 14.808

6.  Relative contributions of age and atherosclerosis to vascular stiffness.

Authors:  Linda C Santelices; Sarah J Rutman; Rachelle Prantil-Baun; David A Vorp; Joseph M Ahearn
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

7.  Hemoglobin α/eNOS coupling at myoendothelial junctions is required for nitric oxide scavenging during vasoconstriction.

Authors:  Adam C Straub; Joshua T Butcher; Marie Billaud; Stephanie M Mutchler; Mykhaylo V Artamonov; Anh T Nguyen; Tyler Johnson; Angela K Best; Megan P Miller; Lisa A Palmer; Linda Columbus; Avril V Somlyo; Thu H Le; Brant E Isakson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-02       Impact factor: 8.311

8.  Circadian control of mouse heart rate and blood pressure by the suprachiasmatic nuclei: behavioral effects are more significant than direct outputs.

Authors:  W John Sheward; Erik Naylor; Seymour Knowles-Barley; J Douglas Armstrong; Gillian A Brooker; Jonathan R Seckl; Fred W Turek; Megan C Holmes; Phyllis C Zee; Anthony J Harmar
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

9.  Cardiovascular and body weight regulation changes in transgenic mice overexpressing thyrotropin-releasing hormone (TRH).

Authors:  María Silvina Landa; Silvia Inés García; Mariano Luis Schuman; Ludmila Soledad Peres Diaz; Maia Aisicovich; Carlos José Pirola
Journal:  J Physiol Biochem       Date:  2020-09-11       Impact factor: 4.158

10.  Salt sensitivity of blood pressure in NKCC1-deficient mice.

Authors:  Soo Mi Kim; Christoph Eisner; Robert Faulhaber-Walter; Diane Mizel; Susan M Wall; Josephine P Briggs; Jurgen Schnermann
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.